NMO Spectrum Disorder: Clinical Trials

1 trial for NMO Spectrum Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow NMO Spectrum Disorder: new trials by email Literature Review of NMO Spectrum Disorder trials Research Report on NMO Spectrum Disorder

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Disorder
Azathioprine - NMO Spectrum Disorder, Azathioprine Adverse Reaction
Phase 4CompletedFirst Affiliated Hospital of Guangxi Medical University632020-01-012023-06-09

Narrower conditions

Neuromyelitis Optica (1)

Broader conditions

Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Cranial Nerve Diseases (1)  ·  Demyelinating Autoimmune Diseases, CNS (1)  ·  Demyelinating Diseases (1)  ·  Eye Diseases (1)  ·  Immune System Diseases (1)  ·  Myelitis, Transverse (1)  ·  Nervous System Diseases (1)  ·  Optic Nerve Diseases (1)  ·  Optic Neuritis (1)

Interventions

Azathioprine (1)

Sponsors

First Affiliated Hospital of Guangxi Medical University (1)

Countries

China (1)

Top investigators

Yulan Tang (1)